Efficacy and safety of micropulse laser trabeculoplasty for primary open angle glaucoma.
intraocular pressure
micropulse laser trabeculoplasty
primary open angle glaucoma
Journal
International journal of ophthalmology
ISSN: 2222-3959
Titre abrégé: Int J Ophthalmol
Pays: China
ID NLM: 101553860
Informations de publication
Date de publication:
2019
2019
Historique:
received:
07
01
2019
accepted:
12
03
2019
entrez:
28
5
2019
pubmed:
28
5
2019
medline:
28
5
2019
Statut:
epublish
Résumé
To evaluate the efficiency and safety of micropulse laser trabeculoplasty (MLT) for primary open angle glaucoma (POAG) patients. Retrospective study. POAG patients undergoing MLT in Peking University Third Hospital from June 2016 to November 2017. Seventy-two eyes of 72 POAG patients were enrolled. Only one eye of each patient was treated by MLT. The intraocular pressure (IOP) before MLT and at 1d, 1, 4, 12 and 24wk and glaucoma medication before and after treatment were compared. The IOP was 20.6±5.9 mm Hg before MLT and 20.8±6.8 mm Hg at 2h after MTL. The IOP at 1d, 1, 4, 12 and 24wk was 17.9±4.4, 18.0±4.3, 17.5±3.4, 17.0±2.7, and 16.5±2.9 mm Hg, respectively. The IOP before and after MLT demonstrated a statistically significant difference by ANOVA analyses ( MLT is effective and safe for POAG patients. No patient experienced IOP spikes after MLT. The IOP 6mo after treatment decreased significantly with less glaucoma medication.
Identifiants
pubmed: 31131237
doi: 10.18240/ijo.2019.05.13
pii: ijo-12-05-784
pmc: PMC6520269
doi:
Types de publication
Journal Article
Langues
eng
Pagination
784-788Références
Ophthalmology. 2001 Apr;108(4):773-9
pubmed: 11297496
Br J Ophthalmol. 2005 Nov;89(11):1500-5
pubmed: 16234461
Bull Soc Belge Ophtalmol. 2008;(308):21-8
pubmed: 18700451
Eur J Ophthalmol. 2009 May-Jun;19(3):429-34
pubmed: 19396790
Clin Ophthalmol. 2008 Jun;2(2):247-52
pubmed: 19668712
Acta Ophthalmol. 2012 Aug;90(5):441-4
pubmed: 21054817
Ophthalmology. 2011 Nov;118(11):2296-302
pubmed: 21849211
Retina. 2012 Feb;32(2):375-86
pubmed: 21971077
Eye (Lond). 2012 Feb;26(2):307-14
pubmed: 22079961
Curr Opin Ophthalmol. 2012 Mar;23(2):111-7
pubmed: 22186007
Eur J Ophthalmol. 2014 May-Jun;24(3):371-4
pubmed: 24170515
PLoS One. 2013 Dec 19;8(12):e84270
pubmed: 24367649
JAMA Ophthalmol. 2014 Apr 1;132(4):403-8
pubmed: 24435815
JAMA. 2014 May 14;311(18):1901-11
pubmed: 24825645
Surv Ophthalmol. 2014 Jul-Aug;59(4):434-47
pubmed: 24837853
Drug Res (Stuttg). 2015 Mar;65(3):164-8
pubmed: 24871930
Surv Ophthalmol. 2015 Jan-Feb;60(1):36-50
pubmed: 25113610
Semin Ophthalmol. 2014 Sep-Nov;29(5-6):397-402
pubmed: 25325865
JAMA Ophthalmol. 2015 Feb;133(2):206-12
pubmed: 25429421
Clin Ophthalmol. 2015 Jul 20;9:1347-51
pubmed: 26229426
BMC Ophthalmol. 2015 Aug 19;15:107
pubmed: 26286384
J Glaucoma. 2016 Jul;25(7):e663-7
pubmed: 26325273
Br J Ophthalmol. 2016 Jan;100(1):94-7
pubmed: 26377417
Medicine (Baltimore). 2015 Dec;94(49):e2075
pubmed: 26656331
Cochrane Database Syst Rev. 2017 Feb 23;2:CD010746
pubmed: 28231380
Exp Eye Res. 1995 Apr;60(4):359-71
pubmed: 7789416
Ophthalmology. 1998 Nov;105(11):2082-8; discussion 2089-90
pubmed: 9818610